Shares of Verona Pharma plc (NASDAQ:VRNA – Get Free Report) have been given an average recommendation of “Buy” by the six analysts that are presently covering the firm, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the […]
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) CEO David Zaccardelli sold 8,616 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The shares were sold at an average price of $2.47, for a total value of $21,281.52. Following the completion of the transaction, the chief executive officer now owns […]
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) insider Kathleen A. Rickard sold 19,736 shares of Verona Pharma stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $2.68, for a total value of $52,892.48. Following the transaction, the insider now owns 2,966,400 shares of the […]
Verona Pharma plc (NASDAQ:VRNA – Get Free Report) General Counsel Claire Poll sold 18,608 shares of the company’s stock in a transaction that occurred on Tuesday, August 1st. The stock was sold at an average price of $2.68, for a total transaction of $49,869.44. Following the completion of the sale, the general counsel now directly […]
Verona Pharma plc (NASDAQ:VRNA) Insider Kathleen A Rickard Sells 19,736 Shares theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.